Cargando…
Serum uric acid, disease severity and outcomes in COVID-19
BACKGROUND: The severity of coronavirus disease 2019 (COVID-19) is highly variable between individuals, ranging from asymptomatic infection to critical disease with acute respiratory distress syndrome requiring mechanical ventilation. Such variability stresses the need for novel biomarkers associate...
Autores principales: | Dufour, Inès, Werion, Alexis, Belkhir, Leila, Wisniewska, Anastazja, Perrot, Marie, De Greef, Julien, Schmit, Gregory, Yombi, Jean Cyr, Wittebole, Xavier, Laterre, Pierre-François, Jadoul, Michel, Gérard, Ludovic, Morelle, Johann |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8201458/ https://www.ncbi.nlm.nih.gov/pubmed/34127048 http://dx.doi.org/10.1186/s13054-021-03616-3 |
Ejemplares similares
-
SARS-CoV-2 causes a specific dysfunction of the kidney proximal tubule
por: Werion, Alexis, et al.
Publicado: (2020) -
Urine metabolomics links dysregulation of the tryptophan-kynurenine pathway to inflammation and severity of COVID-19
por: Dewulf, Joseph P., et al.
Publicado: (2022) -
High response rate to BNT162b2 mRNA COVID-19 vaccine among self-care dialysis patients
por: Georgery, Hélène, et al.
Publicado: (2021) -
Immunosuppression and SARS-CoV-2 Infection in Kidney Transplant Recipients
por: Devresse, Arnaud, et al.
Publicado: (2022) -
Safe use of hydroxychloroquine and its combination with azithromycin in the context of Sars-CoV-2 outbreak: Clinical experience in a Belgian tertiary center
por: Pothen, Lucie, et al.
Publicado: (2020)